BioHealth News

Fast Company Recognizes GeneDx as One of the World’s Most Innovative Companies

Fast Company Recognizes GeneDx as One of the World’s Most Innovative Companies

GeneDx recognized for its innovative approach to accelerating genetic diagnosis and transforming the future of healthcare by ending the diagnostic odyssey GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx…

Read More
Welldoc Achieves 50+ Patents, Unveiling “CGM-GPT” for Advanced Glucose Prediction

Welldoc Achieves 50+ Patents, Unveiling “CGM-GPT” for Advanced Glucose Prediction

Digital Health Leader's Innovation in Real-Time Sensor-Based AI Sets New Standards for Personalized Cardiometabolic Care COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a digital health leader revolutionizing cardiometabolic…

Read More
Governor Glenn Youngkin Announces Luna Labs to Expand Research and Development Operations in Charlottesville

Governor Glenn Youngkin Announces Luna Labs to Expand Research and Development Operations in Charlottesville

Technology development company will invest $200,000 and create 20 new jobs  RICHMOND, VA — Governor Glenn Youngkin today announced that Luna Labs USA, LLC, a…

Read More
Sapio Sciences: Seamless AI-Native Drug Discovery with NVIDIA BioNeMo

Sapio Sciences: Seamless AI-Native Drug Discovery with NVIDIA BioNeMo

BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform. This…

Read More
BioPharmaDive: AstraZeneca adds ‘in vivo’ cell therapy capabilities with EsoBiotech deal

BioPharmaDive: AstraZeneca adds ‘in vivo’ cell therapy capabilities with EsoBiotech deal

The British drugmaker is paying up to $1 billion to buy the Belgian startup, whose technology it sees as useful in treating cancer as well…

Read More
Phlow Corp. Achieves Key Milestone Toward Full Epinephrine Production — Made in America

Phlow Corp. Achieves Key Milestone Toward Full Epinephrine Production — Made in America

Validation Completed for a Novel, Cost-Competitive Epinephrine Active Pharmaceutical Ingredient Process, Drug Master File Successfully Filed Richmond, Virginia, March 17, 2025 (GLOBE NEWSWIRE) --…

Read More
The Economic Power of NIH Grants: Why Sustained Investment Matters

The Economic Power of NIH Grants: Why Sustained Investment Matters

The National Institutes of Health (NIH) is vital in driving scientific discovery and economic growth across the United States. Recent reports from United for…

Read More
Motivity Secures $27M Investment to Scale ABA Tech with NIH Entrepreneur in Residence Support

Motivity Secures $27M Investment to Scale ABA Tech with NIH Entrepreneur in Residence Support

HONOLULU, HI, Mar. 12, 2025 – Motivity, a leading provider of clinical SaaS solutions for Applied Behavior Analysis (ABA) providers who treat children with…

Read More
WBJ: This Md. biotech wants to get a cancer treatment to patients. It just tapped an industry outsider as co-CEO

WBJ: This Md. biotech wants to get a cancer treatment to patients. It just tapped an industry outsider as co-CEO

By Sara Gilgore – Staff Reporter, Washington Business Journal -Mar 12, 2025 - Gaithersburg’s Shuttle Pharmaceuticals Holdings Inc. (NASDAQ: SHPH) has brought in a…

Read More
CEL-SCI’s Head and Neck Cancer Study Clears FDA Review, Eyes Commercialization Partners

CEL-SCI’s Head and Neck Cancer Study Clears FDA Review, Eyes Commercialization Partners

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today announced it received comments from the U.S. Food and Drug Administration (FDA) on the confirmatory Registration…

Read More
Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease

Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease

BETHESDA, Md., March 14, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery…

Read More
GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis

GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Multiscore, an advanced AI-powered decision support tool…

Read More
Emergent and Rocketvax Partner on Next-Gen Product Development

Emergent and Rocketvax Partner on Next-Gen Product Development

GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across…

Read More
Rockville’s Cellphire Therapeutics CLPH-511 Fast Track Designation Granted

Rockville’s Cellphire Therapeutics CLPH-511 Fast Track Designation Granted

Rockville, Md. (March 11, 2025) – Cellphire Therapeutics, Inc., a clinical stage biotechnology company developing next-generation allogeneic, platelet-derived, cellular therapeutics, is excited to announce…

Read More
IonQ Raises Over $372 Million Via At-the-Market Equity Offering Program

IonQ Raises Over $372 Million Via At-the-Market Equity Offering Program

COLLEGE PARK, Md.--(BUSINESS WIRE)-- IonQ, Inc. (NYSE: IONQ), a leader in the quantum computing and quantum networking industries, today announced that under its “at-the-market” equity…

Read More